Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.981
+0.050 (5.41%)
Jan 3, 2025, 4:00 PM EST - Market closed
Processa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 8 | 18 | 77 | 70 | 99 | |
| Market Cap Growth | -27.52% | -53.15% | -77.16% | 10.52% | -29.44% | -29.07% | |
| Enterprise Value | 0 | 2 | 9 | 58 | 71 | 98 | |
| Last Close Price | 0.98 | 6.69 | 22.00 | 98.00 | 131.90 | 360.00 | |
| PB Ratio | 0.86 | 1.65 | 2.35 | 3.02 | 3.04 | 12.32 | |
| P/TBV Ratio | 1.20 | 1.65 | 2.35 | 4.42 | 4.94 | - | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.00 | 0.01 | 0.13 | |
| Quick Ratio | 2.37 | 6.44 | 6.51 | 17.06 | 12.82 | 0.58 | |
| Current Ratio | 3.97 | 7.71 | 8.40 | 18.87 | 13.27 | 0.85 | |
| Return on Equity (ROE) | -211.71% | -178.52% | -166.43% | -47.20% | -93.14% | -37.91% | |
| Return on Assets (ROA) | -113.11% | -99.41% | -72.18% | -27.98% | -22.29% | -21.05% | |
| Return on Capital (ROIC) | -132.05% | -111.54% | -76.12% | -29.61% | -24.90% | -25.93% | |
| Earnings Yield | -359.83% | -134.94% | -155.91% | -14.84% | -20.69% | -3.40% | |
| FCF Yield | -347.29% | -97.87% | -54.61% | -11.32% | -4.51% | -2.78% | |
| Buyback Yield / Dilution | -117.51% | -62.83% | -5.16% | -104.27% | -35.72% | -3.63% | |
| Total Shareholder Return | -117.51% | -62.83% | -5.16% | -104.27% | -35.72% | -3.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.